|
Azacitidine in the management of patients with myelodysplastic syndromes.
|
Dec 2012
|
Ther Adv Hematol
|
myelodysplastic syndromes (MDS)
|
|
Aplastic anemia: therapeutic updates in immunosuppression and transplantation
|
Dec 2012
|
Hematology Am Soc Hematol Educ Program
|
aplastic anemia
|
|
Interpreting new molecular genetics in myelodysplastic syndromes
|
Dec 2012
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
|
Myelodysplastic syndromes: who and when in the course of disease to transplant
|
Dec 2012
|
Hematology Am Soc Hematol Educ Program
|
myelodysplastic syndromes (MDS)
|
|
Can hypomethylating agents provide a platform for curative therapy in myelodysplastic syndromes?
|
Dec 2012
|
Best Pract Res Clin Haematol
|
myelodysplastic syndromes (MDS)
|
|
Emerging immunosuppressive drugs in myelodysplastic syndromes
|
Dec 2012
|
Expert Opin Emerg Drugs
|
myelodysplastic syndromes (MDS)
|
|
Unrelated cord blood transplantation in a child with very severe aplastic anemia
|
Dec 2012
|
Rinsho Ketsueki
|
aplastic anemia
|
|
Treatment and hematopoietic SCT in aplastic anemia
|
Nov 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Diagnosis of acquired aplastic anemia
|
Nov 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
|
Front-line immunosuppressive treatment of acquired aplastic anemia
|
Nov 2012
|
Bone Marrow Transplant
|
aplastic anemia
|
